Septic Shock With Multiorgan Failure: From Conventional Apheresis to Adsorption Therapies

Seminars in Dialysis

Volumn 25, Issue 2, 2012, Pages 171-175

  Stegmayr, Bernd ^a,b   Abdel Rahman, Emaad M ^c   Balogun, Rasheed A ^c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Dialysis Center North   (Germany)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; CRITICAL ILLNESS; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MORTALITY; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEPTIC SHOCK; SURVIVAL; SWEDEN; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; CAUSE OF DEATH; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RISK ASSESSMENT; SHOCK, SEPTIC; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 84858698167     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01029.x     Document Type: Article

References (37)

1. Calandra T, Cohen J: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Critical Care Med 33(7):1538-1548, 2005
2. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103(2):565-575, 1993
3. Lameire N, Van Biesen W, Vanholder R: Epidemiology, clinical evaluation, and prevention of acute renal failure. Feehally JFJ, Johnson RJ (eds). Comprehensive Clinical Nephrology. Philadelphia, PA: Mosby Elsevier, 2007:771-785
4. Cruz DN, Bolgan I, Perazella MA, Bonello M, de Cal M, Corradi V, Polanco N, Ocampo C, Nalesso F, Piccinni P, Ronco C: North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. Clin J Am Soc Nephrol 2(3):418-425, 2007
5. Bagshaw SM, George C, Bellomo R: Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 12(2):R47, 2008
6. Soubrier S, Leroy O, Devos P, Nseir S, Georges H, d'Escrivan T, Guery B: Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration. J Crit Care 21(1):66-72, 2006
7. Stegmayr B: Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Transfus Apher Sci 38(3):203-208, 2008
8. Ponikvar R: Blood purification in the intensive care unit. Nephrol Dial Transplant 18(Suppl. 5):v63-v67, 2003
9. Rabindranath KS, Adams J, MacLeod AM, Muirhead N: Intermittent versus continuous renal replacement therapy for acute renal failure in adults (Review). Cochrane Database of Syst Rev (3):1-50, 2008
10. Bouchard J, Weidemann C, Mehta RL: Renal replacement therapy in acute kidney injury: intermittent versus continuous? How much is enough? Adv Chronic Kidney Dis 15(3):235-247, 2008
11. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300, 2010
12. Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Critical Care Med 32(8):1662-1668, 2004
13. Balogun RA: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis. Critical Care Med 33(2):461-462, 2005
14. Okusa MD, Balogun RA: Pharmacological Interventions in Acute Kidney Injury. Himmelfarb J, Sayegh H (eds.). Chronic Kidney Disease, Dialysis & Transplantation, a Companion Text to Brenner and Rector's The Kidney, 3rd edn. Philadelphia: Elsevier Saunders, 2010:678-686
15. Fortenberry JD, Paden ML: Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis 17(2):72-79, 2006
16. Miwa K, Fukuyama M, Ida N, Igarashi H, Uchiyama T: Preparation of a superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo. Int J Infect Dis 7(1):21-26, 2003
17. Amoureux MC, Rajapakse N, Hegyi E, Le D, Grandics P, Szathmary S: Endotoxin removal from whole blood by a novel adsorption resefficiency and hemocompatibility. Int J Artif Organs 27(6):480-487, 2004
18. Nilsson A, Fant C, Nyden M, Holmberg K: Lipopolysaccharide removal by a peptide-functionalized surface. Colloids Surf B Biointer 40(2):99-106, 2005
19. Staubach KH, Boehme M, Zimmermann M, Otto V: A new endotoxin adsorption device in Gram-negative sepsis: use of immobilized albumin with the MATISSE adsorber. Transfus Apher Sci 29(1):93-98, 2003
20. Tani T, Shoji H, Guadagni G, Perego A: Extracorporeal removal of endotoxthe polymyxin B-immobilized fiber cartridge. Contrib Nephrol 167:35-44, 2010
21. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 19(4):361-368, 2001, discussion 368-369
22. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301(23):2445-2452, 2009
23. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23(5):400-405, 2005
24. Stegmayr B, Tarnvik A: Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration. Blood Purif 7(1):10-15, 1989
25. Kotitschke R, Borberg H, Güsken G: Long-term study of the protein profiles in healthy volunteers after plasma exchange. Bambauer RMP, Falkenhagen D (eds). Therapeutic Plasma Exchange and Selective Plasma Separation. Stuttgart: Schattauer, 1987:199-204
26. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Critical Care Med 27(10):2096-2104, 1999
27. Busund R, Koukline V, Utrobin U, Nedashkovsky E: Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 28(10):1434-1439, 2002
28. Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med 36(10):2878-2887, 2008
29. Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T: Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 31(6):1730-1736, 2003
30. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaud P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7):862-871, 2002
31. Schrier RW: Fluid administration in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 5(4):733-739, 2010
32. Holmberg B, Stegmayr BG: Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodial Int 13(1):27-31, 2009
33. Stegmayr BG: A survey of blood purification techniques. Transfus Apher Sci 32(2):209-220, 2005
34. Stegmayr BG: Three purse-string sutures allow immediate start of peritoneal dialysis with a low incidence of leakage. Semin Dial 16(4):346-348, 2003
35. Stegmayr BG, Banga R, Lundberg L, Wikdahl AM, Plum-Wirell M: PD treatment for severe congestive heart failure. Perit Dial Int 16(Suppl. 1):S231-S235, 1996
36. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahasi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif Organs 22(12):1038-1044, 1998
37. Suzuki H, Nemoto H, Nakamoto H, Okada H, Sugahara S, Kanno Y, Moriwaki K: Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Therap Apher 6:234-240, 2002